Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
0.3083
-0.0209 (-6.35%)
At close: May 12, 2025, 4:00 PM
0.3500
+0.0417 (13.53%)
After-hours: May 12, 2025, 7:58 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $19.16 million as of May 12, 2025. Its market cap has decreased by -74.92% in one year.
Market Cap
19.16M
Enterprise Value
-32.12M
1-Year Change
-74.92%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $19.16M, a decrease of -98.00%. That is a compound annual growth rate of -52.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 20.46M | -41.59% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | 1.16B | 21.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |